Axsome Therapeutics, Inc. (LON:0HKF)

Axsome Therapeutics Statistics

Total Valuation

LON:0HKF has a market cap or net worth of GBP 6.88 billion. The enterprise value is 6.80 billion.

Market Cap	6.88B
Enterprise Value	6.80B

Important Dates

The next estimated earnings date is Monday, February 23, 2026.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.41M
Shares Outstanding	n/a
Shares Change (YoY)	+3.38%
Shares Change (QoQ)	+1.17%
Owned by Insiders (%)	1.14%
Owned by Institutions (%)	77.31%
Float	42.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.48
PB Ratio	125.44
P/TBV Ratio	472.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-39.83
EV / Sales	16.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-90.18

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.96.

Current Ratio	1.57
Quick Ratio	1.45
Debt / Equity	2.96
Debt / EBITDA	n/a
Debt / FCF	-2.16
Interest Coverage	-25.65

Financial Efficiency

Return on equity (ROE) is -275.50% and return on invested capital (ROIC) is -42.17%.

Return on Equity (ROE)	-275.50%
Return on Assets (ROA)	-19.79%
Return on Invested Capital (ROIC)	-42.17%
Return on Capital Employed (ROCE)	-63.06%
Weighted Average Cost of Capital (WACC)	6.54%
Revenue Per Employee	511,699
Profits Per Employee	-209,258
Employee Count	816
Asset Turnover	0.91
Inventory Turnover	2.40

Taxes

Income Tax	-650,948
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.93% in the last 52 weeks. The beta is 0.43, so LON:0HKF's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+38.93%
50-Day Moving Average	168.08
200-Day Moving Average	129.65
Relative Strength Index (RSI)	59.11
Average Volume (20 Days)	269

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.18

Income Statement

In the last 12 months, LON:0HKF had revenue of GBP 417.55 million and -170.75 million in losses. Loss per share was -3.47.

Revenue	417.55M
Gross Profit	383.58M
Operating Income	-144.95M
Pretax Income	-171.41M
Net Income	-170.75M
EBITDA	-139.82M
EBIT	-144.95M
Loss Per Share	-3.47

Balance Sheet

The company has 241.98 million in cash and 162.62 million in debt, with a net cash position of 79.36 million.

Cash & Cash Equivalents	241.98M
Total Debt	162.62M
Net Cash	79.36M
Net Cash Per Share	n/a
Equity (Book Value)	54.85M
Book Value Per Share	1.09
Working Capital	152.55M

Cash Flow

In the last 12 months, operating cash flow was -75.10 million and capital expenditures -326,590, giving a free cash flow of -75.43 million.

Operating Cash Flow	-75.10M
Capital Expenditures	-326,590
Free Cash Flow	-75.43M
FCF Per Share	n/a

Margins

Gross margin is 91.86%, with operating and profit margins of -34.71% and -40.89%.

Gross Margin	91.86%
Operating Margin	-34.71%
Pretax Margin	-41.05%
Profit Margin	-40.89%
EBITDA Margin	-33.49%
EBIT Margin	-34.71%
FCF Margin	n/a

Dividends & Yields

LON:0HKF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.38%
Shareholder Yield	-3.38%
Earnings Yield	-2.48%
FCF Yield	-1.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HKF has an Altman Z-Score of 2.8 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	4